PBI logo

PBI

Pitney Bowes Inc.

$9.63
+$0.24(+2.56%)
60
Overall
80
Value
41
Tech
--
Quality
Market Cap
$1.48B
Volume
3.00M
52W Range
$6.88 - $13.11
Target Price
$14.00

Latest News for PBI

Pitney Bowes Announces Cash Tender Offers for Notes
TipRanks Auto-Generated Newsdesk2 days agoNov 21, 2025

Pitney Bowes ( ($PBI) ) has provided an announcement. On November 21, 2025, Pitney Bowes announced the commencement of cash tender offers to purcha......

Paradigm Biopharmaceuticals’ AGM Resolutions Passed Successfully
TipRanks Australian Auto-Generated Newsdesk5 days agoNov 19, 2025

The latest announcement is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals Limited announced the successful passing......

Paradigm Biopharmaceuticals Secures Additional Funding Through Convertible Notes
TipRanks Australian Auto-Generated Newsdesk7 days agoNov 17, 2025

Paradigm Biopharmaceuticals ( ($AU:PAR) ) just unveiled an announcement. Paradigm Biopharmaceuticals has issued a Cleansing Notice related to the i......

Paradigm Biopharmaceuticals Issues 5 Million Convertible Notes
TipRanks Australian Auto-Generated Newsdesk7 days agoNov 17, 2025

The latest announcement is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals Limited announced the issuance of 5,000,......

Paradigm Biopharmaceuticals Secures Funding for Global Clinical Expansion
TipRanks Australian Auto-Generated Newsdesk7 days agoNov 17, 2025

An update from Paradigm Biopharmaceuticals ( ($AU:PAR) ) is now available. Paradigm Biopharmaceuticals has completed a US$5 million drawdown under ......

POSaBIT’s Earnings Call: Profitability and Expansion Focus
TipRanks Auto-Generated Newsdesk10 days agoNov 14, 2025

POSaBIT Systems Corp (($TSE:PBIT)) has held its Q3 earnings call. Read on for the main highlights of the call. POSaBIT Systems Corp’s recent earnin......

Paradigm Biopharmaceuticals Announces Change in Substantial Shareholder Status
TipRanks Australian Auto-Generated Newsdesk12 days agoNov 12, 2025

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has shared an update. Paul Rennie, a significant shareholder in Paradigm Biopharmaceuticals, has ceased t......

News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.

ABCD
1SymbolPriceChangeVol
2PBI$9.63+2.6%3.00M
3
4
5
6

Get Pitney Bowes Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.